Abstract
MicroRNAs play an important role in the regulation of expression of many genes involved in cancer pathogenesis. One of the causes of miRNA level deregulation in tumors is the methylation of CpG islands in the promoter regions of the genes that encode them. Hypermethylation may lead to the suppression of miRNA gene expression and, as a consequence, to a decrease in their inhibitory effect on target gene mRNAs. A search for new miRNA genes hypermethylated in breast cancer has been carried out in the present study. The methylation of five miRNA genes associated with breast cancer (miR-132, miR-1258, miR-107, miR-130b, miR-137) has been as studied using a representative set of 41 breast cancer samples by methylation-specific PCR. Three new genes, MIR-132, MIR-137 and MIR-1258, with a high frequency of hypermethylation (41, 37 and 34%, respectively) have been identified in breast cancer. The methylation of these genes in the breast tissues of ten donors without cancer pathology in anamnesis was only found in single cases. These results enable the involvement of three miRNAs (miR-132, miR-137, miR-1258) and the methylation of the genes that encode them in the pathogenesis of breast cancer to be suggested.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Dey S. 2014. Preventing breast cancer in LMICs via screening and/or early detection: The real and the surreal. World J. Clin. Oncol. 5, 509–519.
Kaprin A.D., Starinskii V.V., Petrova G.V. 2015. Zlokachestvennye novoobrazovaniya v Rossii v 2013 godu (zabolevaemost’ i smertnost’) (Malignant Neoplasms in Russia in 2013: Morbidity and Mortality). Moscow: MNIOI im. P.A. Gertsena.
Jones P.A. 2012. Functions of DNA methylation: Islands, start sites, gene bodies and beyond. Nat. Rev. Genet. 13, 484–492.
Kato M., Slack F.J. 2008. microRNAs: Small molecules with big roles—C. elegans to human cancer. Biol. Cell. 100, 71–81.
Kunej T., Godnic I., Ferdin J., Horvat S., Dovc P., Calin G.A. 2011. Epigenetic regulation of microRNAs in cancer: An integrated review of literature. Mutat. Res. 717, 77–84.
Zhang Z.G., Chen W.X., Wu Y.H., Liang H.F., Zhang B.X. 2014. MiR-132 prohibits proliferation, invasion, migration, and metastasis in breast cancer by targeting HN1. Biochem. Biophys. Res. Commun. 454, 109–114.
Tang D., Zhang Q., Zhao S., Wang J., Lu K., Song Y., Zhao L., Kang X., Wang J., Xu S., Tian L. 2013. The expression and clinical significance of microRNA-1258 and heparanase in human breast cancer. Clin. Biochem. 46, 926–932.
Han Y., Bi Y., Bi H., Diao C., Zhang G., Cheng K., Yang Z. 2015. miR-137 suppresses the invasion and procedure of EMT of human breast cancer cell line MCF-7 through targeting CtBP1. Hum. Cell. 29, 1–7.
Stückrath I., Rack B., Janni W., Jäger B., Pantel K., Schwarzenbach H. 2015. Aberrant plasma levels of circulating miR-16, miR-107, miR-130a and miR-146a are associated with lymph node metastasis and receptor status of breast cancer patients. Oncotarget. 6, 13387–13401.
Chang Y.Y., Kuo W.H., Hung J.H., Lee C.Y., Lee Y.H., Chang Y.C., Lin W.C., Shen C.Y., Huang C.S., Hsieh F.J., Lai L.C., Tsai M.H., Chang K.J., Chuang E.Y. 2015. Deregulated microRNAs in triple-negative breast cancer revealed by deep sequencing. Mol. Cancer. 14, 36.
Loginov V.I., Malyukova A.V., Seryogin Yu.A., Khodyrev D.S, Kazubskaya T.P., Ermilova V.D., Garkavtseva R.F., Kisselev L.L, Zabarovsky E.R., Braga E.A. 2004. Methylation of the promoter region of the RASSF1A candidate tumor suppressor gene in primary epithelial tumors. Mol. Biol. (Moscow). 38 (4), 549–560.
Pronina I.V., Loginov V.I., Burdennyy A.M., Fridman M.V., Kazubskaya T.P., Dmitriev A.A., Braga E.A. 2016. Expression and DNA methylation alterations of seven cancer-associated 3p genes and their predicted regulator miRNAs (miR-129-2, miR-9-1) in breast and ovarian cancers. Gene. 576, 483–491.
Sobin L.H., Wittekind C. 2002. TNM Classification of Malignant Tumours, 6th ed. New York: Wiley.
Tavassoli F.A., Devilee P. 2003. World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Breast and Female Genital Organs. Lyon: IARC Press.
Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., Baylin S.B. 1996. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. U. S. A. 93, 9821–9826.
Loginov V.I., Dmitriev A.A., Senchenko V.N., Pronina I.V., Khodyrev D.S., Kudryavtseva A.V., Krasnov G.S., Gerashchenko G.V., Chashchina L.I., Kazubskaya T.P., Kondratieva T.T., Lerman M.I., Angeloni D., Braga E.A., Kashuba V.I. 2015. Tumor suppressor function of the SEMA3B gene in human lung and renal cancers. PLOS ONE. 10, e0123369.
Lee K.H., Lotterman C., Karikari C., Omura N., Feldmann G., Habbe N., Goggins M.G., Mendell J.T., Maitra A. 2009. Epigenetic silencing of microRNA miR-107 regulates cyclin-dependent kinase 6 expression in pancreatic cancer. Pancreatology. 9, 293–301.
Yang C., Cai J., Wang Q., Tang H., Cao J., Wu L., Wang Z. 2012. Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1. Gynecol. Oncol. 124, 325–334.
Balaguer F., Link A., Lozano J.J., Cuatrecasas M., Nagasaka T., Boland C.R., Goel A. 2010. Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis. Cancer Res. 70, 6609–6618.
Rykov S.V., Khodyrev D.S., Pronina I.V., Kazubskaya T.P., Loginov V.I., Braga E.A. 2013. Novel miRNA genes methylated in lung tumors. Russ. J. Genet. 49 (7), 782–786.
Zhang S., Hao J., Xie F., Hu X., Liu C., Tong J., Zhou J., Wu J., Shao C. 2011. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development. Carcinogenesis. 32, 1183–1189.
Formosa A., Lena A.M., Markert E.K., Cortelli S., Miano R., Mauriello A., Croce N., Vandesompele J., Mestdagh P., Finazzi-Agrò E., Levine A.J., Melino G., Bernardini S., Candi E. 2013. DNA methylation silences miR-132 in prostate cancer. Oncogene. 32, 127–134.
Sato F., Tsuchiya S., Meltzer S.J., Shimizu K. 2011. MicroRNAs and epigenetics. FEBS J. 278, 1598–1609.
Dacic S., Kelly L., Shuai Y., Nikiforova M.N. 2010. miRNA expression profiling of lung adenocarcinomas: Correlation with mutational status. Mod. Pathol. 23, 1577–1582.
Zhu X., Li Y., Shen H., Li H., Long L., Hui L., Xu W. 2013. miR-137 inhibits the proliferation of lung cancer cells by targeting Cdc42 and Cdk6. FEBS Lett. 587, 73–81.
Vrba L., Muñoz-Rodríguez J.L., Stampfer M.R., Futscher B.W. 2013. miRNA gene promoters are frequent targets of aberrant DNA methylation in human breast cancer. PLoS ONE. 8, e54398.
Liu H., Chen X., Gao W., Jiang G. 2012. The expression of heparanase and microRNA-1258 in human non-small cell lung cancer. Tumour Biol. 33, 1327–1334.
Zhang L., Sullivan P.S., Goodman J.C., Gunaratne P.H., Marchetti D. 2011. MicroRNA-1258 suppresses breast cancer brain metastasis by targeting heparanase. Cancer Res. 71, 645–654.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © V.I. Loginov, A.M. Burdennyy, I.V. Pronina, V.V. Khokonova, S.V. Kurevljov, T.P. Kazubskaya, N.E. Kushlinskii, E.A. Braga, 2016, published in Molekulyarnaya Biologiya, 2016, Vol. 50, No. 5, pp. 797–802.
Rights and permissions
About this article
Cite this article
Loginov, V.I., Burdennyy, A.M., Pronina, I.V. et al. Novel miRNA genes hypermethylated in breast cancer. Mol Biol 50, 705–709 (2016). https://doi.org/10.1134/S0026893316050101
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0026893316050101